AK-104 (ANTI-PD1/ANTI-CTLA4 BISPECIFIC ANTIBODY AK104)
According to the NCI website, anti-PD-1/CTLA-4 bispecific antibody AK104 is a bispecific antibody directed against the human negative immunoregulatory checkpoint receptors programmed cell death protein 1. Check for active clinical trials using this agent. (NCI Thesaurus)
Copyright 2023. All Rights Reserved.
You are using an outdated browser. The website may not be displayed correctly. Close